About Laboratorio Farmaci Antiblastici
Clinical Trials at Laboratorio Farmaci Antiblastici
During the past decade, Laboratorio Farmaci Antiblastici conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Laboratorio Farmaci Antiblastici"
#1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Laboratorio Farmaci Antiblastici
According to Clinical.Site data, the most researched conditions in "Laboratorio Farmaci Antiblastici" are
"Prostate Cancer" (2 trials), "Cancer of the Prostate" (1 trials) and "Nonmetastatic Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Laboratorio Farmaci Antiblastici" in a lesser frequency.
Clinical Trials Intervention Types at Laboratorio Farmaci Antiblastici
Most popular intervention types in "Laboratorio Farmaci Antiblastici" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Enzalutamide" (2 trials), "Abiraterone" (1 trials), "Placebo" (1 trials), "Placebo for Enzalutamide" (1 trials) and "Prednisone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Laboratorio Farmaci Antiblastici
The vast majority of trials in "Laboratorio Farmaci Antiblastici" are
2 trials for "Male" genders.
Clinical Trials Status at Laboratorio Farmaci Antiblastici
Currently, there are NaN active trials in "Laboratorio Farmaci Antiblastici".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Laboratorio Farmaci Antiblastici,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Laboratorio Farmaci Antiblastici, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".